Alcohol consumption can affect glycemic control, and the combination of GLP-1 therapy with alcohol might increase hypoglycemia risk, particularly in patients taking concomitant insulin or sulfonylureas
Ellingsgaard H, Hauselmann I, Schuler B et al (2015) Interleukin-6 enhances insulin secretion by increasing glucagon- like peptide-1 secretion from L cells and alpha cells
Medications such as GLP-1 therapies (including tirzepatide and semaglutideZepbound, Mounjaro, Wegovy, and Ozempic) can be powerful tools, but they are only one part of a safe, effective, and sustainable metabolic care strategy
While these drugs have not undergone large-scale clinical trials like their branded counterparts, you can still prescribe them responsibly by adhering to established best practices for safety and compliance
Some weight loss medications may be covered through your pharmacy benefits, and well help you look into those options
bland, low-fat, low-fiber foods might sit better around training times if youre sensitive